AstraZeneca - Seroquel: Dan Carlat cuts to the quick

“It’s pretty clear that if a drug poses a diabetes risk in one country, it poses that risk in others,” Dan Carlat, a psychiatrist at Tufts University in Boston who writes a blog about the health-care industry, said in an interview. “I don’t think it’s ethical to warn doctors in Japan about this drug and then downplay or ignore the risk in the U.S.”

Source